Cara Therapeutics
CARA
#10379
Rank
โ‚ฌ1.48 M
Marketcap
0,32ย โ‚ฌ
Share price
-6.08%
Change (1 day)
-57.72%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2024 (TTM): โ‚ฌ6.58 Million

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ6.51 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ18.96 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ6.85 M-63.84%
2023 โ‚ฌ18.96 M-51.4%
2022 โ‚ฌ39.03 M91.95%
2021 โ‚ฌ20.33 M-81.49%
2020 โ‚ฌ0.10 B518.67%
2019 โ‚ฌ17.75 M50.77%
2018 โ‚ฌ11.77 M1450.68%
2017 โ‚ฌ0.75 M828.64%
2016 โ‚ฌ0.08 M-97.65%
2015 โ‚ฌ3.47 M33.15%
2014 โ‚ฌ2.61 M-69.85%
2013 โ‚ฌ8.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.73 M-88.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ91.58 M 1,306.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ68.74 M 955.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.59 M-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.03 B 891,395.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.02 B 1,244,414.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 1,520.62%๐Ÿ‡บ๐Ÿ‡ธ USA